Hormone-responsive, patient-derived models of the uterine wall in a microfluidic array
This study developed a microfluidic organ-on-a-chip platform to create patient-derived, hormone-responsive 3D models of the uterine wall. Researchers successfully seeded endometrial epithelial and stromal cells with myometrial smooth muscle cells in a specific sequence to mimic native tissue architecture, achieving robust self-organization within microwells. The resulting cultures demonstrated functional responsiveness to estradiol, medroxyprogesterone acetate, and cAMP, evidenced by increased secretion of decidualization markers IGFBP-1 and osteopontin. This paper is centrally about endometriosis and adenomyosis — explicitly stated in the introduction as chronic gynaecological disorders that remain under-researched and for which these advanced in vitro models are intended to provide new screening tools.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
3,977 characters
· extracted from
oa-pdf
· 7 sections
· click to expand
Abstract
Introduction
Materials and methods
Results
Conclusions
References
Acknowledgements
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-05-11T07:51:59.466421+00:00